| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 08/01/2007 | EP1812797A2 Compositions and methods for the treatment and prevention of hyperproliferative diseases |
| 08/01/2007 | EP1812560A1 Retina-specific cells differentiated in vitro from bone marrow stem cells, the production thereof and their use |
| 08/01/2007 | EP1812468A2 Platelet factor 4 variant 1 (pf4var1) related inhibitors of angiogenesis |
| 08/01/2007 | EP1812387A1 2,3,4-substituted cyclopentanones as therapeutic agents |
| 08/01/2007 | EP1812020A1 Presbyopia treatment by lens alteration |
| 08/01/2007 | EP1812017A2 Ophthamological drugs |
| 08/01/2007 | EP1812000A1 Aqueous ophthalmic suspension of crystalline rebamipide |
| 08/01/2007 | EP1572071A4 Systems and methods for treating patients with processed lipoaspirate cells |
| 08/01/2007 | EP1546130B1 Piperidine derivatives for use in the treatment of chemokine mediated disease states |
| 08/01/2007 | EP1484327B1 Nitrogenous heterocyclic compound and medicine thereof |
| 08/01/2007 | EP1461038B1 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders |
| 08/01/2007 | EP1419158B1 Pteridinone derivatives as modulators of chemokine receptor activity |
| 08/01/2007 | EP1259235B1 Tyrosine kinase inhibitors |
| 08/01/2007 | EP1242098B1 Aqueous ionic solutions and their uses in particular in ophthalmology |
| 08/01/2007 | EP1187592B1 Alpha v integrin receptor antagonists |
| 08/01/2007 | CN1329389C Novel compounds and their use |
| 08/01/2007 | CN1329388C 1,3,5-triazine derivatives as ligands for human adenosine-A3 receptors |
| 08/01/2007 | CN1329040C Use of zijing in preparing preparation for treating shortsightedness |
| 08/01/2007 | CN1329034C Method for preventing/treating damage to sensory hair cells and cochlear neurons |
| 08/01/2007 | CN101007803A Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 08/01/2007 | CN101007173A Anti-angiogene compositions and methods of use |
| 08/01/2007 | CN101007054A Drug for treating cataract |
| 08/01/2007 | CN101007001A Therapeutic methods and compositions involving isoflavones |
| 08/01/2007 | CN101007000A Therapeutic methods and compositions involving isoflavones |
| 08/01/2007 | CN101006999A Therapeutic methods and compositions involving isoflavones |
| 08/01/2007 | CN101006974A Ophthalmic gel and its preparation method |
| 08/01/2007 | CN101006860A Smoke-roasting bamboo salt and its making method |
| 08/01/2007 | CN101006807A Mix oil containing linoleic acid and linolenic acid in the ratio of 4 to 1 |
| 08/01/2007 | CN101006806A Mix oil containing linoleic acid and linolenic acid in the ratio of 4 to 1 |
| 08/01/2007 | CN101006805A Mix oil containing linoleic acid and linolenic acid in the ratio of 4 to 1 |
| 07/31/2007 | US7250403 Administration of immunomodulatory polynucleotide microcarrier complexes featuring a polynucleotide comprising at least one immunostimulatory sequence bound to a biodegradable microcarrier or noncarrier |
| 07/31/2007 | US7250285 Isolated nucleic acid; screening for antibacterial compounds |
| 07/31/2007 | CA2412596C Cyclic gmp-specific phosphodiesterase inhibitors |
| 07/26/2007 | WO2007084765A2 Injectable combination therapy for eye disorders |
| 07/26/2007 | WO2007084473A2 The use of memantine and brimonidine to attenuate vitreoretinal vascular endothelial growth factor (vegf) protein levels in animals |
| 07/26/2007 | WO2007084332A2 Memantine for the normalization of visual acuity deficits |
| 07/26/2007 | WO2007083689A1 Plasminogen activator inhibitor-1 inhibitor |
| 07/26/2007 | WO2007083145A1 The treatment of ocular conditions and the systemic side-effects of glucocorticoids |
| 07/26/2007 | WO2007082561A2 Method for the treatment of tinnitus |
| 07/26/2007 | WO2007058971A3 Soft anticholinergic esters |
| 07/26/2007 | WO2007056087A8 Prostaglandins and analogues as agents for lowering intraocular pressure |
| 07/26/2007 | WO2007045407A3 Nutraceutical and pharmaceutical compositions containing choline as adiuvants for the prevention and treatment of retinopathies and glaucoma |
| 07/26/2007 | US20070173548 Malonamic acids and derivatives thereof as thyroid receptor ligands |
| 07/26/2007 | US20070173454 Administering an agent that decreases or regulates the blood level, production, function or activity of gonadotropins-leutinizing hormone, follicle stimulating hormone, activin or follistatin; parkinson's disease |
| 07/26/2007 | US20070173436 Compositions and methods for enhancing drug delivery across and into epithelial tissues |
| 07/26/2007 | US20070172532 Complex Mixtures Exhibiting Selective Inhibition of Cyclooxygenase-2 |
| 07/26/2007 | CA2636644A1 The use of memantine and brimonidine to attenuate vitreoretinal vascular endothelial growth factor (vegf) protein levels in animals |
| 07/25/2007 | EP1810715A2 Combination comprising an agent decreasing VEGF activity and an agent decreasing EGF activity |
| 07/25/2007 | EP1809270A1 5,6,7-trihydroxyheptanoic acid and analogs for the treatment of ocular diseases and diseases associated with hyperproliferative and angiogenic responses |
| 07/25/2007 | EP1809240A2 Cardiac safe, rapid medication delivery |
| 07/25/2007 | EP1809238A2 Ophthalmic emulsions containing an immunosuppressive agent |
| 07/25/2007 | EP1499600B1 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors |
| 07/25/2007 | EP1397364B1 Novel pyrrole derivatives as pharmaceutical agents |
| 07/25/2007 | EP1355873B1 Pleuromutilin derivatives with antimicrobial activity |
| 07/25/2007 | EP1349580B1 Process to improve stability of a pharmaceutical composition |
| 07/25/2007 | EP1263763B1 Tubulin binding ligands |
| 07/25/2007 | CN1328247C N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substiituent on the methyl useful as bradykinin antagonists |
| 07/25/2007 | CN1327876C Chinese drugs compositions for treating diabetes and its complications |
| 07/25/2007 | CN1327863C Chinese medicine for treating acute or purulent otitis media and the preparation thereof |
| 07/25/2007 | CN101005844A Muscarinic antagonists with PARP and SIR modulatng activity as agents for inflammatory diseases |
| 07/25/2007 | CN101005834A Eyewash liquid for dry eye therapy |
| 07/25/2007 | CN101003573A Human antibodies that bind human tnfalpha |
| 07/25/2007 | CN101003542A Sterilization compound in broad spectrum and usage |
| 07/25/2007 | CN101002895A Traditional Chinese medicine for treating animal's ear diseases |
| 07/25/2007 | CN101002813A Dripping pills for clearing heat and expelling-coagulates, and its preparing method |
| 07/25/2007 | CN101002775A Anti-inflective preparation |
| 07/25/2007 | CN101002774A Anti-inflammatory and sterilizing preparation |
| 07/25/2007 | CN101002760A Application of chlorogenic acid for preparing medicine to treat diabetes complications |
| 07/25/2007 | CN101002623A Beverage with function of preventing and curing presbyopia, and its preparing method |
| 07/24/2007 | US7247636 Phenolic guanidine sodium channel blockers |
| 07/19/2007 | WO2007080902A1 Composition inhibiting the expression of target gene in eyeball and remedy for disease in eyeball |
| 07/19/2007 | WO2007033020A3 Ophthalmic formulation for treatment of dry eye |
| 07/19/2007 | US20070167493 Novel compounds for the management of aging-related and diabetic vascular complications, process for their preparation, therapeutic and cosmetic uses thereof |
| 07/19/2007 | US20070167461 USE OF SUBSTITUTED 2-PYRIDINYL-6,7,8,9-TETRAHYDROPYRIMIDO[1,2-a] PYRIMIDIN-4-ONE AND 7-PYRIDINYL-2,3-DIHYDROIMIDAZO[1,2-a] PYRIMIDIN-5(1H)ONE DERIVATIVES AS THERAPEUTIC AGENTS |
| 07/19/2007 | US20070167373 Combined use of a GLP-1 compound and a modulator of diabetic late complications |
| 07/19/2007 | US20070167372 Ocular tear growth factor-like protein |
| 07/19/2007 | US20070167371 Treating deficient tear output and enhancing the proliferation of human corneal epithelial cells by contacting the ocular surface or the cells with a lacrimal gland protein that has activity as a growth factor on both human corneal epithelial cells and on the lacrimal acinar cells that produce it. |
| 07/18/2007 | EP1808490A2 Genetically engineered bleb vaccine |
| 07/18/2007 | EP1808170A1 Aqueous eye drops with accelerated intraocular migration |
| 07/18/2007 | EP1808158A2 Presbyopia treatment by lens alteration |
| 07/18/2007 | EP1453514B1 Piperazine derivatives for use as ccr-3 receptor antagonists in the treatment of asthma |
| 07/18/2007 | EP1284698B1 Method of pre-selecting a polymerizable fluid formed into an intraocular lens |
| 07/18/2007 | EP1150678B1 Use of 3-hydroxy-3-methylglutaryl coenzym a reductase inhibitors for the manufacture of a medicament for the treatment of diabetic neuropathy |
| 07/18/2007 | EP0859751B2 Semi-fluorinated alkanes and their use |
| 07/18/2007 | CN1326879C Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same |
| 07/18/2007 | CN1326848C Aminopyrazole derivatives |
| 07/18/2007 | CN1326563C Use of the long pentraxin PTX3 for the preparation of medicament for the prevention and cure of autoimmune pathologies |
| 07/18/2007 | CN1326560C Use of POLY-GLU,TYR treated therewith for neuroprotective therapy |
| 07/18/2007 | CN100998869A Anti-angiogene compositions and methods of use |
| 07/18/2007 | CN100998864A Cyclosporin A semisolid skeleton capsule and its preparation method |
| 07/18/2007 | CN100998863A N-acetyl carnosine eye drops for preventing and treating cataract and its preparation method |
| 07/18/2007 | CN100998768A Oral traditional Chinese medicine for treating chronic conjunctivitis |
| 07/18/2007 | CN100998753A Oral traditional Chinese medicine for treating red-eye type hypertension |
| 07/18/2007 | CN100998704A Medicine for treating tympanitis |
| 07/18/2007 | CN100998699A Oral traditional Chinese medicine for treating acute bacterial conjunctivitis |
| 07/18/2007 | CN100998695A Eye-washing medicine for treating acute conjunctivitis |
| 07/18/2007 | CN100998655A Method for preparing medicine to treat childhood amblyopia |
| 07/18/2007 | CN100998636A Traditional Chinese medicine for treating acute conjunctivitis |
| 07/18/2007 | CN100998619A Medicated food for treating chronic conjunctivitis |
| 07/18/2007 | CN100998586A L-dopa methyl ester eye preparation preparing method and use thereof |